Technology thesis · Biotechnology & Health
medium conviction emergingSpatial biology
Spatial biology's resolution wars are over and 10x Genomics won; the 2026-2028 fight is whether spatial earns a reimbursed clinical-diagnostic role or stays a pharma research tool.
Position maintained continuously · last reviewed Jun 24, 2026
The thesis
Core thesis
Technologies like 10x Genomics Visium and Vizgen MERFISH map RNA expression at single-cell resolution within tissue sections. This reveals not just what genes are active but where in the tissue — critical for understanding tumour microenvironments and drug mechanisms. Market growing 30%+ annually but still early-stage for clinical applications.
State of the art (2026)
Spatial biology in 2026 is a 10x Genomics-led market consolidating fast. At AACR in April 2026 10x unveiled Atera, a whole-transcriptome in situ platform it calls its most significant launch ever, shipping in the second half of the year and stacking on top of Xenium Prime 5K and Visium HD. The challengers have been absorbed rather than beaten: Bruker now runs the former NanoString CosMx and GeoMx lines and shipped a CosMx whole-transcriptome panel, while Quanterix acquired Akoya, folding PhenoCycler proteomics into a tissue-plus-blood biomarker play. The open question is no longer resolution or plex — those are largely solved — but whether spatial earns a reimbursed clinical role rather than staying a pharma and academic research tool.
Everything below is live inside CanaryIQ
The full analysis behind the verdict — the structure is real; the content unlocks when you log in.
Signal stack
Evidence stacked leading → lagging
Technology-native KPIs
Metrics that predict trajectory, tracked over time
Landscape map
Who builds what — and who depends on whom
Catalyst calendar
Dated events that will move the position
Technology roadmap
Milestones on the path to maturity
Watchlists
Companies, people and papers — each with a remove-by condition
Decision frameworks
The same call, framed for your desk
Thesis changelog
When our view changed, and why
Change our mind
3 disconfirming conditions
The rest is inside
You've read the verdict. The file is much deeper.
The full signal stack, technology-native KPIs tracked over time, the landscape of who depends on whom, the dated catalyst calendar, decision frameworks for every desk, live watchlists and the changelog of every time our call on Spatial biology has changed — all live inside CanaryIQ.